Related Experiment Video
Updated: Jan 8, 2026

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer
Published on: February 20, 2020
Hand Grip Strength as a Functional Marker of Sarcopenia in Liver Cirrhosis: Evidence from an Indian Cohort
Shyam Sunder1, Narayan Lal Yadav2, Prabhat Narain Sharma3
1Professor, Department of Medicine, ESIC Medical College and Hospital, Jaipur, Rajasthan, India.
Background:
Sarcopenia is a frequent and prognostically significant complication of liver cirrhosis. Hand grip strength (HGS) has emerged as a simple, noninvasive tool for assessing muscle function, yet limited data exist on its utility in Indian cirrhotic populations.
Aim:
To evaluate the association of HGS with established prognostic scores and biochemical parameters in Indian patients with cirrhosis.
Materials And Methods:
In this cross-sectional observational study, 100 adult cirrhotic patients were assessed between August 2022 and December 2023. HGS was measured using a validated hand-held dynamometer. Correlations between HGS and clinical scores of severity of cirrhosis [Child-Turcotte-Pugh (CTP), Model for End-Stage Liver Disease (MELD)] and biochemical markers were analyzed using appropriate statistical methods.
Results:
Mean patient age was 59.2 ± 8.46 years; 85% were male. The most common etiologies were alcohol (46%) and viral hepatitis (26%). HGS declined significantly with increasing liver disease severity: CTP A (34.0 ± 1.48 kg), B (21.63 ± 1.07 kg), and C (13.5 ± 2.87 kg) (p < 0.0001). HGS was inversely correlated with MELD score (r = -0.820) and showed strong positive correlations with serum albumin (r = +0.872) and hemoglobin (r = +0.59). Age, international normalized ratio (INR), and bilirubin were negatively correlated with HGS.
Conclusion:
HGS is strongly associated with liver disease severity and key biochemical indicators. As a bedside, radiation-free tool, it offers a practical method for assessing sarcopenia in cirrhosis, especially in resource-limited settings.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

